Zebra Technologies
ZBRA
$361.61
+3.07%
Zebra Technologies is the largest global provider of automatic identification and data capture (AIDC) technology, selling barcode printers and scanners, mobile computers, RFID readers, and workflow-optimization software to enterprises in retail, transportation and logistics, manufacturing, and healthcare. Its competitive moat rests on an entrenched installed base, switching costs embedded in customer workflows, and a razor-and-blade model spanning hardware, supplies, and software — a positioning that makes it a picks-and-shovels play on supply-chain digitization rather than a commodity hardware vendor. The current investor narrative centers on a sharp fundamental inflection: after a multi-quarter demand trough, Zebra delivered a strong Q1 2026 earnings beat with raised guidance, and the stock gapped roughly 26% higher on August 4, 2026, on what appears to be a major AI/automation-driven order cycle. The debate now is whether this is the start of a durable multi-year replacement and AI-edge upgrade cycle or a pull-forward of demand that has already been priced into a stock trading near the top of its 52-week range.…
ZBRA
Zebra Technologies
$361.61
Related headlines
ZBRA 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Zebra Technologies's 12-month outlook, with a consensus price target around $411.45 and implied upside of +13.8% versus the current price.
Average Target
$411.45
0 analysts
Implied Upside
+13.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$350 - $455
Analyst target range
Coverage is robust with 15 analysts, and the consensus recommendation is "buy" with a recommendation mean of 1.94 (where 1.0 is a strong buy and 3.0 is a hold). The average target price is $411.45, implying roughly +18.7% upside from the current $346.63, with a low target of $350.00 (essentially at the current price) and a high target of $455.00 (+31.3%). The consensus leans bullish, and the fact that even the lowest target sits at or above the current price suggests analysts see limited downside from here.
The target range of $350–$455 is moderately wide (~30% spread), signaling meaningful uncertainty about the magnitude of the AI-driven upgrade cycle but strong directional conviction. The high target of $455 likely assumes multiple expansion on accelerating EVM growth and successful integration of the recent acquisition, while the low target of $350 prices in a scenario where growth normalizes and margins compress. Institutional ratings show a constructive tilt: KeyBanc upgraded to Overweight from Sector Weight on May 13, 2026, and firms including Barclays (Overweight), BNP Paribas (Outperform), Baird (Outperform), and Needham (Buy) maintain positive ratings, while Citigroup and Truist remain Neutral/Hold — a split that reflects the debate over whether the August gap already captured the good news. The absence of any Sell ratings and the clustering of targets above the current price indicate the Street views the post-earnings dip as a buying opportunity rather than a warning.
Drowning in data?
Find the real signal!
Bulls vs Bears: ZBRA Investment Factors
The bull case currently has stronger evidence, anchored by a confirmed revenue inflection (14.3% YoY growth in Q1 2026), a forward P/E of 15.61x that is undemanding if estimates are met, and unanimous analyst buy ratings with an average target of $411.45. However, the bear case is not without merit: the stock has stalled since its August 4 gap, beta is elevated at 1.607, and the forward estimates embed a steep ramp that could disappoint. The single most important tension is whether the AI/automation-driven order cycle is durable or a pull-forward of demand; if it proves durable, the forward multiple is a bargain, but if it fades, the stock could retest its 52-week low of $199.05. Given the strong fundamental momentum and analyst conviction, the balance of evidence favors the bulls, but the post-gap consolidation and high beta warrant caution.
Bullish
- Revenue inflection confirmed: Q1 2026 revenue of $1.495B grew 14.3% YoY and marked the fourth consecutive sequential increase from $1.293B in Q2 2025, signaling the demand trough is firmly in the past. The raised guidance and August 4 gap of ~26% suggest an accelerating AI/automation-driven order cycle rather than a one-time pull-forward.
- Forward P/E of 15.6x is cheap: The stock trades at a trailing P/E of 29.47x but a forward P/E of just 15.61x, implying the market expects EPS to roughly double to the consensus estimate of $29.90. This dramatic compression suggests the valuation is undemanding if the AI upgrade cycle delivers.
- Gross margin expansion of ~500bp: Gross margin expanded from 44.61% in Q4 2025 to 49.63% in Q1 2026, a meaningful ~500bp sequential improvement driven by favorable mix, pricing, and cost actions. This margin leverage amplifies earnings growth as revenue scales.
- Strong analyst conviction with upside: 15 analysts rate the stock a 'buy' with a mean of 1.94, and the average target of $411.45 implies ~18.7% upside from $346.63. Even the lowest target of $350 sits above the current price, indicating limited perceived downside.
Bearish
- Post-gap momentum has stalled: After the August 4 surge from $291.64 to $368.83, the stock has consolidated in a $341–$383 band and is down 2.26% over the past month, with relative strength versus SPY at -1.30%. This deceleration suggests the market may have already priced in the good news.
- High beta amplifies downside: With a beta of 1.607, Zebra is roughly 61% more volatile than the market, and its historical max drawdown is -39.18%. In a risk-off environment or if growth disappoints, the stock could correct violently.
- Liquidity is tight with current ratio below 1: The current ratio of 0.97 is slightly below 1.0, reflecting the $1.3B acquisition in Q4 2025 that drew cash down from $1.053B to $125M. This leaves little cushion and makes liquidity dependent on continued operating cash generation.
- Forward estimates embed a steep ramp: The forward P/E of 15.61x relies on EPS reaching $29.90, which implies a very steep earnings ramp. Any shortfall in the AI-driven order cycle would quickly make the trailing multiple of 29.47x look full and trigger a de-rating.
ZBRA Technical Analysis
Zebra is in a powerful, sustained uptrend that has carried the shares 7.36% over the trailing year but an extraordinary 70.23% over six months and 46.89% over three months, with the current price of $346.63 sitting at roughly 79% of the 52-week range (52-week low $199.05, 52-week high $386.23). That positioning — well above the midpoint but still about 10% below the high — signals a stock in momentum leadership that has not yet become fully extended at the highs, though the vertical nature of the advance raises mean-reversion risk. The 39.60% year-to-date gain versus the S&P 500's 11.70% underscores genuine relative strength rather than beta-driven drift, with relative strength versus SPY at +27.90% YTD and +52.79% over six months.
Short-term momentum, however, has decelerated sharply from the August surge: the stock is down 2.26% over the past month and 0.34% on the latest session, with relative strength versus SPY at -1.30% over one month — a clear divergence from the explosive three-month trend. This pattern is classic post-gap digestion: after the August 4 move from $291.64 to $368.83 (a ~26% single-day repricing), the stock has consolidated in a $341–$383 band, and the 1-month stall looks like profit-taking and base-building rather than trend reversal, especially given the 3-month gain of 46.89%. The 1-year relative strength of -7.65% versus SPY is the one cautionary data point, implying the trailing twelve months include a long stretch of underperformance before the recent breakout.
Key technical levels are well defined: support sits at the $341–$344 zone (recent September lows of $341.18 and $342.73) with deeper support at the 52-week low of $199.05, while resistance is the 52-week high of $386.23 and the August intraday peak near $383. A breakout above $386 would confirm the next leg of the uptrend and likely open a move toward analyst targets, whereas a breakdown below $341 would signal the post-earnings gap is failing and expose the $300 area. With a beta of 1.607, Zebra is roughly 61% more volatile than the market, meaning position sizing should be materially smaller than a market-weight allocation, and the -39.18% max drawdown on record is a reminder that this name can correct violently when the cycle turns.
Beta
1.61
1.61x market volatility
Max Drawdown
-38.3%
Largest decline past year
52-Week Range
$199-$386
Price range past year
Annual Return
+14.6%
Cumulative gain past year
| Period | ZBRA Return | S&P 500 |
|---|---|---|
| 1m | -1.9% | +1.0% |
| 3m | +45.9% | +5.5% |
| 6m | +76.9% | +19.9% |
| 1y | +14.6% | +16.0% |
| ytd | +45.6% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ZBRA Fundamental Analysis
Zebra's revenue trajectory has inflected decisively upward: Q1 2026 (ended April 4, 2026) revenue of $1.495 billion grew 14.3% year over year against $1.308 billion in the prior-year quarter, and marked the fourth consecutive sequential increase from $1.293B (Q2 2025), $1.320B (Q3 2025), and $1.475B (Q4 2025). Segment data shows Enterprise Visibility & Mobility (EVM) at $865 million and Asset Intelligence & Tracking (AIT) at $455 million, with EVM — the larger, mobile-computing-led franchise — carrying the bulk of the growth. The multi-quarter cadence (roughly $1.29B → $1.32B → $1.48B → $1.50B) indicates the demand trough is behind the company and that the raised guidance referenced in recent news is grounded in an accelerating order book rather than one-time pull-forward.
Profitability is solid and improving: Q1 2026 net income was $135 million on a 9.03% net margin, with gross margin of 49.63% (gross profit of $742 million) and operating margin of 14.38% ($215 million operating income). Gross margin has expanded from 44.61% in Q4 2025 and 48.03% in Q3 2025 to 49.63% in the latest quarter, a meaningful ~500bp sequential improvement that reflects favorable mix, pricing, and cost actions. The company is comfortably profitable with a trailing P/E of 29.47x and a 7.77% net margin on a TTM basis, and the Q1 EPS of $2.68 versus $2.62 a year ago shows earnings leverage on the revenue rebound.
Balance-sheet and cash-flow metrics are healthy but warrant monitoring: debt-to-equity stands at 0.78, the current ratio is 0.97 (slightly below 1.0, reflecting the $1.3 billion acquisition in Q4 2025 that drew down cash from $1.053 billion to $125 million), and ROE is 11.68% with ROA of 7.32%. Free cash flow remains robust at $836 million TTM and $163 million in Q1 2026, though the Q1 FCF was dampened by a $300 million share repurchase and $149 million of debt repayment; the company also returned capital aggressively while funding the acquisition. The cash-flow-to-debt ratio of 0.062 and interest coverage of 5.81x indicate the leverage is manageable but not trivial, and the low current ratio means liquidity depends on continued operating cash generation — which the business is delivering.
Quarterly Revenue
$1.5B
2026-04
Revenue YoY Growth
+14.3%
YoY Comparison
Gross Margin
49.6%
Latest Quarter
Free Cash Flow
$836000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ZBRA Overvalued?
Because Zebra is solidly profitable (Q1 2026 net income of $135 million; TTM EPS positive), the P/E ratio is the appropriate primary metric. The stock trades at a trailing P/E of 29.47x versus a forward P/E of just 15.61x — a dramatic ~47% compression that implies the market expects earnings to roughly double, consistent with the consensus FY EPS estimate of $29.90 and the raised guidance. That forward multiple is the crux of the bull case: if the AI/automation upgrade cycle delivers, Zebra is optically cheap on forward earnings despite the sharp price run.
On other multiples, the picture is more mixed: PS ratio of 2.29x, EV/Sales of 3.29x, EV/EBITDA of 17.62x, P/B of 3.44x, and P/CF of 13.46x. Against a Technology sector where high-quality hardware/software hybrids often command 20–30x EV/EBITDA, Zebra's 17.62x looks reasonable rather than stretched, and the 2.29x PS is modest for a company with 49.6% gross margins and a dominant market position. The negative PEG ratio of -1.50 is a data artifact of prior-period earnings volatility and should be disregarded; the forward P/E of 15.61x against expected EPS growth is the more meaningful signal, suggesting the valuation is not demanding if estimates are met.
Historically, Zebra's P/E has ranged from the low-20s to over 200x during the 2023 earnings trough, and its PS ratio has compressed from 21.7x in Q4 2021 to 2.29x today — a massive de-rating that reflects both the post-COVID normalization and the recent earnings recovery. At 29.47x trailing and 15.61x forward, the stock sits in the lower half of its own historical P/E band, which supports the argument that the market is not pricing in heroic assumptions despite the 70% six-month move. The risk is that the forward estimate of $29.90 EPS embeds a very steep ramp; any shortfall would quickly make the trailing multiple look full.
PE
29.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 18x~44x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.6x
Enterprise Value Multiple
Investment Risk Disclosure
Zebra's financial and operational risks are moderate but noteworthy. The debt-to-equity ratio of 0.78 and interest coverage of 5.81x indicate manageable leverage, but the current ratio of 0.97—below 1.0—reflects the $1.3B acquisition in Q4 2025 that reduced cash from $1.053B to $125M, leaving liquidity dependent on continued operating cash flow. Additionally, the forward P/E of 15.61x relies on EPS reaching $29.90, a steep ramp from the trailing EPS; any revenue deceleration or margin compression could quickly make the trailing P/E of 29.47x look expensive. Revenue concentration in the EVM segment ($865M of $1.495B in Q1 2026) and exposure to cyclical retail and logistics capex add earnings volatility.
Market and competitive risks are significant given the stock's high beta of 1.607 and its 70.23% six-month gain, which leaves it vulnerable to profit-taking and multiple compression. The stock trades at a premium to its own historical PS ratio (2.29x vs. 21.7x in Q4 2021, though that was an anomaly), and any slowdown in the AI/automation narrative could trigger a sharp de-rating. Competitive threats from lower-cost Asian hardware vendors and potential disruption from software-based scanning solutions could pressure margins. Macro sensitivity is elevated: stubborn inflation keeping Fed rates high (as noted in May 2026 news) would compress growth stock multiples, and a recession would curb enterprise IT spending.
In a worst-case scenario, a global recession or a stall in the AI upgrade cycle would cause Zebra's revenue growth to reverse, leading to earnings misses and analyst downgrades. The stock could retest its 52-week low of $199.05, representing a -42.6% decline from the current $346.63. The analyst low target of $350 offers little downside protection, but the historical max drawdown of -39.18% suggests such a move is plausible in a severe downturn. Investors could lose over 40% from current levels if the bull thesis unravels.
